Jason Schulz - GoHealth Executive Officer
| GOCO Stock | USD 11.90 0.40 3.48% |
Executive
Jason Schulz is Executive Officer of GoHealth
| Age | 47 |
| Address | 222 West Merchandise Mart Plaza, Chicago, IL, United States, 60654 |
| Phone | 312 386 8200 |
| Web | https://www.gohealth.com |
Jason Schulz Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jason Schulz against GoHealth stock is an integral part of due diligence when investing in GoHealth. Jason Schulz insider activity provides valuable insight into whether GoHealth is net buyers or sellers over its current business cycle. Note, GoHealth insiders must abide by specific rules, including filing SEC forms every time they buy or sell GoHealth'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jason Schulz over three months ago Acquisition by Jason Schulz of 33334 shares of GoHealth subject to Rule 16b-3 |
GoHealth Management Efficiency
The company has return on total asset (ROA) of (0.0276) % which means that it has lost $0.0276 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1588) %, meaning that it created substantial loss on money invested by shareholders. GoHealth's management efficiency ratios could be used to measure how well GoHealth manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of November 2024, Return On Tangible Assets is likely to drop to -0.06. In addition to that, Return On Capital Employed is likely to grow to -0.07. At this time, GoHealth's Total Assets are very stable compared to the past year. As of the 23rd of November 2024, Non Current Assets Total is likely to grow to about 1.3 B, while Net Tangible Assets are likely to drop (220.4 M).Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Ronald Habursky | Erie Indemnity | N/A | |
| Kate CFA | eHealth | N/A | |
| Leslie Follmer | Aon PLC | N/A | |
| Bill Matrogran | Erie Indemnity | N/A | |
| Lorianne CPCU | Erie Indemnity | 54 | |
| AU CIC | Erie Indemnity | 55 | |
| Michael Vaughan | Brown Brown | N/A | |
| Mark Bloom | Arthur J Gallagher | 60 | |
| CPCU CLU | Brown Brown | N/A | |
| Eli NewbrunMintz | eHealth | N/A | |
| CIPM CIPP | Erie Indemnity | N/A | |
| Charles Fletcher | Erie Indemnity | N/A | |
| John English | Aon PLC | N/A | |
| Maxim Shishin | CorVel Corp | 49 | |
| Kenneth II | Brown Brown | 48 | |
| John CPA | eHealth | 63 | |
| Gianmarco Tosti | Willis Towers Watson | N/A | |
| Matthew Furman | Willis Towers Watson | 54 | |
| Mark Bertels | CorVel Corp | 60 | |
| Sarah Anderson | Selectquote | 46 | |
| Jeffrey Gurtcheff | CorVel Corp | N/A | |
Management Performance
| Return On Equity | -0.16 | ||||
| Return On Asset | -0.0276 |
GoHealth Leadership Team
Elected by the shareholders, the GoHealth's board of directors comprises two types of representatives: GoHealth inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GoHealth. The board's role is to monitor GoHealth's management team and ensure that shareholders' interests are well served. GoHealth's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GoHealth's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Kelley, Chief Insights | ||
| Melissa Balsan, Chief Officer | ||
| Michael Hargis, Chief Officer | ||
| Shane Cruz, Chief Officer | ||
| Blair Kessler, Chief Officer | ||
| Jason Schulz, Executive Officer | ||
| Stephen Moffat, Chief Officer | ||
| Brendan Shanahan, Chief Officer | ||
| Katherine CPA, Chief Officer | ||
| Vijay Kotte, CEO Director | ||
| Brandon Cruz, CoFounder CoChairman | ||
| Jay Sreedharan, Chief Officer | ||
| Clinton Jones, CoFounder CoChairman | ||
| Mark Monitello, Chief Officer | ||
| Bradley Esq, Chief Secretary | ||
| John III, Vice Relations | ||
| Brian Farley, Chief Sec | ||
| Katherine OHalloran, Interim Officer | ||
| Alison Moriarty, Chief Officer |
GoHealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is GoHealth a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.16 | ||||
| Return On Asset | -0.0276 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | (0.35) % | ||||
| Current Valuation | 660.11 M | ||||
| Shares Outstanding | 10.13 M | ||||
| Shares Owned By Insiders | 14.86 % | ||||
| Shares Owned By Institutions | 54.14 % | ||||
| Number Of Shares Shorted | 204.15 K | ||||
| Price To Earning | 25.59 X |
Pair Trading with GoHealth
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if GoHealth position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GoHealth will appreciate offsetting losses from the drop in the long position's value.Moving together with GoHealth Stock
| 0.88 | EHTH | eHealth | PairCorr |
| 0.83 | AON | Aon PLC | PairCorr |
| 0.67 | BRO | Brown Brown Fiscal Year End 27th of January 2025 | PairCorr |
Moving against GoHealth Stock
| 0.78 | ERIE | Erie Indemnity | PairCorr |
| 0.68 | RELI | Reliance Global Group | PairCorr |
| 0.58 | MMC | Marsh McLennan Companies Fiscal Year End 23rd of January 2025 | PairCorr |
| 0.54 | SLQT | Selectquote Buyout Trend | PairCorr |
| 0.51 | ZBAO | Zhibao Technology Class | PairCorr |
The ability to find closely correlated positions to GoHealth could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GoHealth when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GoHealth - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GoHealth to buy it.
The correlation of GoHealth is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GoHealth moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GoHealth moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GoHealth can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GoHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Property & Casualty Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GoHealth. If investors know GoHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GoHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.241 | Earnings Share (3.29) | Revenue Per Share 69.776 | Quarterly Revenue Growth (0.10) | Return On Assets (0.03) |
The market value of GoHealth is measured differently than its book value, which is the value of GoHealth that is recorded on the company's balance sheet. Investors also form their own opinion of GoHealth's value that differs from its market value or its book value, called intrinsic value, which is GoHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GoHealth's market value can be influenced by many factors that don't directly affect GoHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GoHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if GoHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GoHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.